Title: Obesity
1Obesity Addiction Neuroimaging Studies
Gene-Jack Wang, M.D. Brookhaven Center for
Translational Neuroimaging
2Obesity
Newsday / Walt Handelsman Oct 10, 2002
3Factors Contributing to Obesity
- Culture,
-
- Genetics,
- High energy
- intake,
- Lowered energy
- expenditure,
- Abnormal eating
- behavior.
4Signals that Control Food Intake
Hypothalamus
5Eating Habits
Many obesity researchers focus on how the body's
fuel and fat levels control appetite. But as
comfort eaters know, habits and desires often
override metabolic need.
6Body Weight Drug Treatment
- Drugs (stimulants e.g. amphetamine, cocaine,
methylphenidate) that increase brain dopamine
concentration are anorexigenic. - Drugs (antipsychotic e.g. Haloperidol,.. ) that
block dopamine D2 receptors increase appetite and
result in significant weight gain.
7Dopamine D2 images of Drug Addiction
Cocaine
11Craclopride
8Low Dopamine (DA) State in Addiction
Dopamine
Non Drug Abuser
Addicted Subject
9Obesity
- Compulsive overeating shares many of the same
characteristics as drug addiction.
- Do obese subjects have abnormal dopamine
receptors?
10Dopamine Receptors
11Craclopride
2
0
ml/gm
Control Subjects
Wang et al, Lancet 2001
11Dopamine Receptor and BMI
p lt 0.002
BMI
p 0.3
Dopamine Receptor Concentration
Wang et al, Lancet 2001
12Implication
- Dopamine modulates motivation and reward circuits
and hence dopamine deficiency in obese subjects
may perpetuate pathologic eating as a means to
compensate for the decreased activation of reward
circuits.
13Dopamine
14Food
- Eating is highly reinforcing behavior, just like
taking drugs and as for drugs it can elicit
powerful conditioned responses.
- Are the conditioned responses associated with DA
release? That is would DA be released by viewing
food without eating it?
15Food Stimulation
- 1) Subjects were asked to describe their
favorite foods and how they like to eat them
while they were presented with foods that they
had reported as among their favorite ones. - Food was warmed to enhance the smell and the
subjects were presented with it so that they
could view it and smell it and a cotton swab
impregnated with the food was placed in their
tongues so they could taste it. - A given food item was presented for 4 minutes and
then it was exchanged for a new one.
16Neutral Stimulation
Subjects viewed neutral images and/or were asked
to describe in as much detail as possible their
family genealogy.
17Methylphenidate ( MP) block the Dopamine
Transporter ( )
DA
DA
DA
DA
DA
DA
DA
DA
DA
DA
DA
DA
DA
DA
signal
signal
MP enhances weak signals
18Study Design
Subjects were scanned 4 times with
11Craclopride over a two day period. Six
subjects participated study 1 on the first day
and four subjects participated study 2 on the
first day of the studies
19Brain Dopamine Response to Food Stimulation
Sum images of 10 normal weight subjects
(11Craclopride)
1.5
DA D2 Receptor Availability
0
ml/g
p lt 0.11
p lt 0.02
p lt 0.005
(Bmax/Kd)
Placebo/Neutral
Placebo/Food
MP/Neutral
MP/Food
Volkow, Wang, et al, Synapse 2002
20Extracellular DA vs Self-report of Hunger
Desire for Food Ritalin
r 0.76 p lt 0.01
Desire for Food
Hunger
Change Bmax/kd
Volkow, Wang, et al, Synapse 2002
21Implication
- These results support the role of DA
neurotransmission in dorsal striatum in mediating
food motivation in human brain.
22Brain Metabolic Response to Food Stimulation
85
Food Presentation
0
µmol/100g/min
18FDG
Neutral Presentation
Right
Wang et al, Neuroimage 2004
23Statistical Parameter Map of Metabolic Changes
between Food and Neutral stimulation
- Twelve normal weight subjects.
- Insula is a brain region modulating emotional
responses to appetitive stimuli. - Orbitofrontal cortex is a brain region involved
with salience attribution.
R
Wang et al, Neuroimage 2004
24Metabolism in orbitofrontal cortex during food
stimulation
- Orbitofrontal cortex is a brain region involved
with salience attribution and drive, may underlie
the motivation to procure food, which may be
subjectively experienced as desire for food and
hunger.
Wang et al, Neuroimage 2004
25Implication
- The enhanced orbitofrontal cortex activation by
food stimulation may reflect downstream effects
from dopamine stimulation. - Dopaminergic involvement in the drive for food
consumption in humans is in part mediated by its
effects in orbitofrontal cortex. - The results could explain the deleterious effects
of constant exposure to food stimuli (e.g.
advertisements, candy machines, food channels,
stores) in overeating.
26Brain Activation during Cocaine Theme Interview
18FDG
Wang et al, Life Science 1999
27Cocaine Craving Insular Metabolism
- - Right Insula, p lt 0.01
- O - Left Insula, p lt 0.008
p lt 0.0002
Wang et al, Life Science 1999
28Prospective
Activation of the temporal insula, a brain region
involved with autonomic control, and of the
orbitofrontal cortex, a brain region involved
with expectancy and salience attribution, during
the cocaine theme support their involvement with
craving in cocaine addicted subjects.
29Obesity
VS
Drug Abuse
- What makes obese subjects different from drug
abusers?
30Obesity
- Would obese subjects have an enhanced sensitivity
in the brain regions involved with sensory
processing of the food?
31Averaged FDG images
Control subjects
Obese subjects
55
0
µmol/100g/min
L
R
What brain regions differ?
Wang et al, NeuroReport 2002
32Enhanced Somatosensory Cortex Metabolism in Obese
Subjects
- Ten obese subjects (n 10, BMI gt 40) and 25 lean
subjects (BMI lt 25). - At baseline condition after fasting for 14-16
hours. - Obese subjects had higher metabolism than lean
subjects in the somatosensory areas where the
mouth, lips and tongue are represented.
FDG
Wang et al, NeuroReport 2002
33Implication
- The enhanced activation in somatic parietal areas
for mouth, tongue and lips in obese subjects
suggests that enhanced sensitivity in regions
involved in the sensory processing of food may
make food more rewarding and may be one of the
variables contributing to their excess food
consumption.
34Addiction
Environment
35Brookhaven PET Group
Scientists Joanna Fowler (organic chemist) David
Alexoff (engineer) Helene Benveniste
(anesthesiologist) Anat Biegon (pharmacologist) St
ephen Dewey (anatomist) Yu-Shin Ding (organic
chemist) Richard Ferrieri (physical chemist) S.
John Gatley (pharmacologist) Rita Goldstein
(psychologist) Kuo-Shan Lin (organic
chemist) Jean Logan (theoretical chemist) Yeming
Ma (physical chemist) David Schlyer (inorganic
chemist) Michael Schueller (biomedical
physicist) Frank Telang (neurologist) Peter
Thanos (neuroscientist) Paul Vaska
(physicist) Nora Volkow (psychiatrist) Gene-Jack
Wang (nuclear med physician)
Support Staff Karen Apelskog (protocol
coordinator) Pauline Carter (nurse) Victor Garza
(chemist) Barbara Hubbard (nurse) Millard Jayne
(nurse) Payton King (Lab Technician) Hai-Dee Lee
(Lab Technician) Noel Netusil (nurse) Colleen
Shea (chemist) Azael Villanueva (biomedical
engineering) Donald Warner (electronics) Youwen
Xu (chemist) Lisa Zimmerman (study
coordinator) Post Doctoral/Fellow Nelly Klein
(psychologist) Kim Lindsey (pharmacologist) Igor
Izrailtyan (anesthesiologist) Daryn Moeller
(anesthesiologist) Alex Morgan (physician) Lisa
Cotton (psychologist)
36Support
Department of Energy (Office of Biology
Environmental Research) National Institute on
Drug Abuse Office of National Drug Control Policy